Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
, 79 (12), 1557-61

Osteoporosis Associated With Megestrol Acetate

Case Reports

Osteoporosis Associated With Megestrol Acetate

Robert A Wermers et al. Mayo Clin Proc.


Megestrol acetate is a progestational agent for treatment of metastatic breast cancer and endometrial cancer. Megestrol has also been used as an appetite stimulant for patients with human immunodeficiency virus and malignancy who experience cachexia and wasting; also, megestrol can be beneficial in relieving hot flashes in women and men. Megestrol has been shown to have a glucocorticoidlike effect and has been associated with substantial suppression of plasma estradiol levels. We describe 2 patients who recently presented to our Metabolic Bone Disease Clinic with severe osteoporosis complicated by multiple vertebral fractures experienced while the patients were receiving high-dose megestrol therapy. The patients had evidence of adrenal axis suppression but recovered fully after megestrol was discontinued. We speculate that megestrol was an important factor in the development of osteoporosis and subsequent fractures. Further study is warranted to clarify the relationship between megestrol and its potential for adversely affecting the skeleton.

Similar articles

See all similar articles

Cited by 2 PubMed Central articles

  • Skeletal Sequelae of Cancer and Cancer Treatment
    CJ Stava et al. J Cancer Surviv 3 (2), 75-88. PMID 19412668. - Review
    The publications researched during this review both highlight and emphasize the association between cancer therapies, including chemotherapy and radiotherapy, and skeleta …
  • Drug-induced Musculoskeletal Disorders
    B Bannwarth. Drug Saf 30 (1), 27-46. PMID 17194169. - Review
    Drug-induced musculoskeletal disorders represent a broad clinical spectrum, from asymptomatic biological abnormalities to severe and even life-threatening diseases. Since …

Publication types